{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:29:18Z","timestamp":1790882958262,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,2,17]],"date-time":"2006-02-17T00:00:00Z","timestamp":1140134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2006,2,17]],"date-time":"2006-02-17T00:00:00Z","timestamp":1140134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Breast cancers of different histology have different clinical and prognostic features. There are also indications of differences in aetiology. We therefore evaluated the risk of the three most common histological subtypes in relation to menopausal hormone therapy and other breast cancer risk factors.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We used a population-based case-control study of breast cancer to evaluate menopausal hormone therapy and other breast cancer risk factors for risk by histological subtype. Women aged 50 to 74 years, diagnosed with invasive ductal (n = 1,888), lobular (n = 308) or tubular (n = 93) breast cancer in Sweden in 1993 to 1995 were compared with 3,065 age-frequency matched controls randomly selected from the population. Unconditional logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for ductal, lobular, and tubular cancer.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Women who had used medium potency estrogen alone were at increased risks of both ductal and lobular cancer. Medium potency estrogen-progestin was associated with increased risks for all subtypes, but the estimates for lobular and tubular cancer were higher compared with ductal cancer. We found OR 5.6 (95% CI 3.2\u20139.7) for lobular cancer, OR 6.5 (95% CI 2.8\u201314.9) for tubular cancer and OR 2.3 (95% CI 1.6\u20133.3) for ductal cancer with \u22655 years use of medium potency estrogen-progestin therapy. Low potency oral estrogen (mainly estriol) appeared to be associated with an increased risk for lobular cancer, but the association was strongest for short-term use. Reproductive and anthropometric factors, smoking, and past use of oral contraceptives were mostly similarly related to the risks of the three breast cancer subtypes. Recent alcohol consumption of &gt; 10 g alcohol\/day was associated with increased risk only for tubular cancer (OR 3.1, 95% CI 1.4\u20136.8).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Menopausal hormone therapy was associated with increased risks for breast cancer of both ductal and lobular subtype, and medium potency estrogen-progestin therapy was more strongly associated with lobular compared with ductal cancer. We also found medium potency estrogen-progestin therapy and alcohol to be strongly associated with tubular cancer. With some exceptions, most other risk factors seemed to be similarly associated with the three subtypes of breast cancer.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr1378","type":"journal-article","created":{"date-parts":[[2006,2,24]],"date-time":"2006-02-24T07:30:36Z","timestamp":1140766236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study"],"prefix":"10.1186","volume":"8","author":[{"given":"Lena U","family":"Rosenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Wedr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W","family":"Dickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,2,17]]},"reference":[{"key":"1356_CR1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","volume":"350","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1997","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet. 1997, 350: 1047-1059. 10.1016\/S0140-6736(97)08233-0.","journal-title":"Lancet"},{"key":"1356_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1001\/jama.283.4.485","volume":"283","author":"C Schairer","year":"2000","unstructured":"Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R: Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 2000, 283: 485-491. 10.1001\/jama.283.4.485.","journal-title":"JAMA"},{"key":"1356_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","volume":"362","author":"V Beral","year":"2003","unstructured":"Beral V: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003, 362: 419-427. 10.1016\/S0140-6736(03)14596-5.","journal-title":"Lancet"},{"key":"1356_CR4","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1001\/jama.289.11.1421","volume":"289","author":"CI Li","year":"2003","unstructured":"Li CI, Anderson BO, Daling JR, Moe RE: Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA. 2003, 289: 1421-1424. 10.1001\/jama.289.11.1421.","journal-title":"JAMA"},{"key":"1356_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ijc.11309","volume":"107","author":"F Levi","year":"2003","unstructured":"Levi F, Te VC, Randimbison L, La Vecchia C: Increase in lobular breast cancer incidence in Switzerland. Int J Cancer. 2003, 107: 164-165. 10.1002\/ijc.11309. author reply 166.","journal-title":"Int J Cancer"},{"key":"1356_CR6","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O","volume":"88","author":"CI Li","year":"2000","unstructured":"Li CI, Weiss NS, Stanford JL, Daling JR: Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer. 2000, 88: 2570-2577. 10.1002\/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O.","journal-title":"Cancer"},{"key":"1356_CR7","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1001\/jama.287.6.734","volume":"287","author":"CL Chen","year":"2002","unstructured":"Chen CL, Weiss NS, Newcomb P, Barlow W, White E: Hormone replacement therapy in relation to breast cancer. JAMA. 2002, 287: 734-741. 10.1001\/jama.287.6.734.","journal-title":"JAMA"},{"key":"1356_CR8","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1002\/cncr.10984","volume":"95","author":"JR Daling","year":"2002","unstructured":"Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman SA, Weiss LK, Ursin G, et al: Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer. 2002, 95: 2455-2464. 10.1002\/cncr.10984.","journal-title":"Cancer"},{"key":"1356_CR9","first-page":"593","volume":"11","author":"PA Newcomb","year":"2002","unstructured":"Newcomb PA, Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Storer BE, Willett WC, Stampfer MJ: Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2002, 11: 593-600.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1356_CR10","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1001\/jama.289.24.3254","volume":"289","author":"CI Li","year":"2003","unstructured":"Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, Daling JR: Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA. 2003, 289: 3254-3263. 10.1001\/jama.289.24.3254.","journal-title":"JAMA"},{"key":"1356_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1023\/A:1023634907723","volume":"14","author":"LM Newcomer","year":"2003","unstructured":"Newcomer LM, Newcomb PA, Potter JD, Yasui Y, Trentham-Dietz A, Storer BE, Longnecker MP, Baron JA, Daling JR: Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States). Cancer Causes Control. 2003, 14: 225-233. 10.1023\/A:1023634907723.","journal-title":"Cancer Causes Control"},{"key":"1356_CR12","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/ijc.1279","volume":"92","author":"J Manjer","year":"2001","unstructured":"Manjer J, Malina J, Berglund G, Bondeson L, Garne JP, Janzon L: Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy. Int J Cancer. 2001, 92: 919-922. 10.1002\/ijc.1279.","journal-title":"Int J Cancer"},{"key":"1356_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/1097-0142(19820701)50:1<171::AID-CNCR2820500132>3.0.CO;2-M","volume":"50","author":"PP Rosen","year":"1982","unstructured":"Rosen PP, Lesser ML, Senie RT, Kinne DW: Epidemiology of breast carcinoma III: relationship of family history to tumor type. Cancer. 1982, 50: 171-179.","journal-title":"Cancer"},{"key":"1356_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/bjc.1988.172","volume":"58","author":"M Ewertz","year":"1988","unstructured":"Ewertz M, Duffy SW: Risk of breast cancer in relation to reproductive factors in Denmark. Br J Cancer. 1988, 58: 99-104.","journal-title":"Br J Cancer"},{"key":"1356_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ijc.2910440304","volume":"44","author":"H Stalsberg","year":"1989","unstructured":"Stalsberg H, Thomas DB, Noonan EA: Histologic types of breast carcinoma in relation to international variation and breast cancer risk factors. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Cancer. 1989, 44: 399-409.","journal-title":"Int J Cancer"},{"key":"1356_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/(SICI)1097-0215(19990331)81:1<49::AID-IJC10>3.0.CO;2-7","volume":"81","author":"J Wohlfahrt","year":"1999","unstructured":"Wohlfahrt J, Mouridsen H, Andersen PK, Melbye M: Reproductive risk factors for breast cancer by receptor status, histology, laterality and location. Int J Cancer. 1999, 81: 49-55. 10.1002\/(SICI)1097-0215(19990331)81:1<49::AID-IJC10>3.0.CO;2-7.","journal-title":"Int J Cancer"},{"key":"1356_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/ijc.11465","volume":"107","author":"CI Li","year":"2003","unstructured":"Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Daling JR: Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65\u201379 years of age. Int J Cancer. 2003, 107: 647-651. 10.1002\/ijc.11465.","journal-title":"Int J Cancer"},{"key":"1356_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/(SICI)1097-0215(19980330)76:1<29::AID-IJC6>3.0.CO;2-#","volume":"76","author":"C Magnusson","year":"1998","unstructured":"Magnusson C, Baron J, Persson I, Wolk A, Bergstrom R, Trichopoulos D, Adami HO: Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer. 1998, 76: 29-34. 10.1002\/(SICI)1097-0215(19980330)76:1<29::AID-IJC6>3.0.CO;2-#.","journal-title":"Int J Cancer"},{"key":"1356_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1023\/A:1008817018942","volume":"9","author":"C Magnusson","year":"1998","unstructured":"Magnusson C, Colditz G, Rosner B, Bergstrom R, Persson I: Association of family history and other risk factors with breast cancer risk (Sweden). Cancer Causes Control. 1998, 9: 259-267. 10.1023\/A:1008817018942.","journal-title":"Cancer Causes Control"},{"key":"1356_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6","volume":"81","author":"C Magnusson","year":"1999","unstructured":"Magnusson C, Baron JA, Correia N, Bergstrom R, Adami HO, Persson I: Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer. 1999, 81: 339-344. 10.1002\/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6.","journal-title":"Int J Cancer"},{"issue":"2","key":"1356_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<231::AID-IJC11>3.0.CO;2-R","volume":"80","author":"CM Magnusson","year":"1999","unstructured":"Magnusson CM, Persson IR, Baron JA, Ekbom A, Bergstrom R, Adami HO: The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years. Int J Cancer. 1999, 80 (2): 231-236. 10.1002\/(SICI)1097-0215(19990118)80:2<231::AID-IJC11>3.0.CO;2-R.","journal-title":"Int J Cancer"},{"key":"1356_CR22","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/oxfordjournals.aje.a009515","volume":"147","author":"MC Pike","year":"1998","unstructured":"Pike MC, Ross RK, Spicer DV: Problems involved in including women with simple hysterectomy in epidemiologic studies measuring the effects of hormone replacement therapy on breast cancer risk. Am J Epidemiol. 1998, 147: 718-721.","journal-title":"Am J Epidemiol"},{"key":"1356_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1200\/JCO.20.3.699","volume":"20","author":"G Ursin","year":"2002","unstructured":"Ursin G, Tseng CC, Paganini-Hill A, Enger S, Wan PC, Formenti S, Pike MC, Ross RK: Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?. J Clin Oncol. 2002, 20: 699-706. 10.1200\/JCO.20.3.699.","journal-title":"J Clin Oncol"},{"key":"1356_CR24","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"GL Anderson","year":"2004","unstructured":"Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, et al: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004, 291: 1701-1712. 10.1001\/jama.291.14.1701.","journal-title":"JAMA"},{"key":"1356_CR25","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1038\/sj.bjc.6602617","volume":"92","author":"SA Lee","year":"2005","unstructured":"Lee SA, Ross RK, Pike MC: An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk. Br J Cancer. 2005, 92: 2049-2058. 10.1038\/sj.bjc.6602617.","journal-title":"Br J Cancer"},{"key":"1356_CR26","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1002\/cncr.20250","volume":"100","author":"A Tjonneland","year":"2004","unstructured":"Tjonneland A, Christensen J, Thomsen BL, Olsen A, Overvad K, Ewertz M, Mellemkjaer L: Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study. Cancer. 2004, 100: 2328-2337. 10.1002\/cncr.20250.","journal-title":"Cancer"},{"key":"1356_CR27","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1001\/jama.281.22.2091","volume":"281","author":"SM Gapstur","year":"1999","unstructured":"Gapstur SM, Morrow M, Sellers TA: Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. JAMA. 1999, 281: 2091-2097. 10.1001\/jama.281.22.2091.","journal-title":"JAMA"},{"key":"1356_CR28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/sj.bjc.6601996","volume":"91","author":"C Stahlberg","year":"2004","unstructured":"Stahlberg C, Pedersen AT, Andersen ZJ, Keiding N, Hundrup YA, Obel EB, Moller S, Rank F, Ottesen B, Lynge E: Breast cancer with different prognostic characteristics developing in Danish women using hormone replacement therapy. Br J Cancer. 2004, 91: 644-650.","journal-title":"Br J Cancer"},{"key":"1356_CR29","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1309\/9FEP8U8AUGQNGY3V","volume":"122","author":"NS Goldstein","year":"2004","unstructured":"Goldstein NS, Kestin LL, Vicini FA: Refined morphologic criteria for tubular carcinoma to retain its favorable outcome status in contemporary breast carcinoma patients. Am J Clin Pathol. 2004, 122: 728-739. 10.1309\/9FEP-8U8A-UGQN-GY3V.","journal-title":"Am J Clin Pathol"},{"key":"1356_CR30","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3109\/00016348409156720","volume":"63","author":"G Heimer","year":"1984","unstructured":"Heimer G, Englund D: Estriol: absorption after long-term vaginal treatment and gastrointestinal absorption as influenced by a meal. Acta Obstet Gynecol Scand. 1984, 63: 563-567.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1356_CR31","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1093\/humrep\/15.5.1028","volume":"15","author":"K Takahashi","year":"2000","unstructured":"Takahashi K, Okada M, Ozaki T, Kurioka H, Manabe A, Kanasaki H, Miyazaki K: Safety and efficacy of oestriol for symptoms of natural or surgically induced menopause. Hum Reprod. 2000, 15: 1028-1036. 10.1093\/humrep\/15.5.1028.","journal-title":"Hum Reprod"},{"key":"1356_CR32","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/S0140-6736(98)10233-7","volume":"353","author":"E Weiderpass","year":"1999","unstructured":"Weiderpass E, Baron JA, Adami HO, Magnusson C, Lindgren A, Bergstrom R, Correia N, Persson I: Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet. 1999, 353: 1824-1828. 10.1016\/S0140-6736(98)10233-7.","journal-title":"Lancet"},{"key":"1356_CR33","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/sj.bjc.6602712","volume":"93","author":"G Ursin","year":"2005","unstructured":"Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, Daling JR, Norman SA, Liff JM, Marchbanks PA, et al: Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer. 2005, 93: 364-371. 10.1038\/sj.bjc.6602712.","journal-title":"Br J Cancer"},{"key":"1356_CR34","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/ijc.11307","volume":"106","author":"LM Newcomer","year":"2003","unstructured":"Newcomer LM, Newcomb PA, Trentham-Dietz A, Longnecker MP, Greenberg ER: Oral contraceptive use and risk of breast cancer by histologic type. Int J Cancer. 2003, 106: 961-964. 10.1002\/ijc.11307.","journal-title":"Int J Cancer"},{"key":"1356_CR35","first-page":"101","volume":"183","author":"S Ahmed","year":"1996","unstructured":"Ahmed S, Tartter PI, Jothy S, Brower ST, Bratton J: The prognostic significance of previous benign breast disease for women with carcinoma of the breast. J Am Coll Surg. 1996, 183: 101-104.","journal-title":"J Am Coll Surg"},{"key":"1356_CR36","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1002\/cncr.10555","volume":"94","author":"K Hemminki","year":"2002","unstructured":"Hemminki K, Granstrom C: Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden. Cancer. 2002, 94: 3063-3070. 10.1002\/cncr.10555.","journal-title":"Cancer"},{"key":"1356_CR37","first-page":"855","volume":"8","author":"Y Chen","year":"1999","unstructured":"Chen Y, Thompson W, Semenciw R, Mao Y: Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev. 1999, 8: 855-861.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1356_CR38","first-page":"1061","volume":"12","author":"CI Li","year":"2003","unstructured":"Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Daling JR: The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65\u201379 years of age. Cancer Epidemiol Biomarkers Prev. 2003, 12: 1061-1066.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1356_CR39","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/ije\/16.2.222","volume":"16","author":"I Persson","year":"1987","unstructured":"Persson I, Bergkvist L, Adami HO: Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms. Int J Epidemiol. 1987, 16: 222-228.","journal-title":"Int J Epidemiol"},{"key":"1356_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/13595220152601837","volume":"6","author":"E Banks","year":"2001","unstructured":"Banks E, Beral V, Cameron R, Hogg A, Langley N, Barnes I, Bull D, Elliman J, Harris CL: Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses. J Epidemiol Biostat. 2001, 6: 357-363. 10.1080\/13595220152601837.","journal-title":"J Epidemiol Biostat"},{"key":"1356_CR41","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1093\/jnci\/91.13.1131","volume":"91","author":"E Weiderpass","year":"1999","unstructured":"Weiderpass E, Adami HO, Baron JA, Magnusson C, Bergstrom R, Lindgren A, Correia N, Persson I: Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst. 1999, 91: 1131-1137. 10.1093\/jnci\/91.13.1131.","journal-title":"J Natl Cancer Inst"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr1378\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:56:13Z","timestamp":1728384973000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr1378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,17]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2006,2]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1186\/bcr1378","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,17]]},"assertion":[{"value":"23 August 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R11"}}